DuPont de Nemours (NYSE:DD – Free Report) had its target price raised by Barclays from $156.00 to $176.00 in a research report sent to investors on Wednesday,Benzinga reports. Barclays currently has an overweight rating on the basic materials company’s stock.
A number of other analysts have also commented on DD. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of DuPont de Nemours in a research note on Friday, October 30th. JPMorgan Chase & Co. downgraded DuPont de Nemours from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $172.00 to $145.00 in a research note on Friday, October 9th. Zacks Research lowered shares of DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 17th. Royal Bank Of Canada lowered their price objective on DuPont de Nemours from $176.00 to $160.00 and set an “outperform” rating on the stock in a report on Thursday, October 15th. Finally, The Goldman Sachs Group cut their target price on shares of DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating for the company in a research report on Wednesday, September 30th. Twelve research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, DuPont de Nemours presently has an average rating of “Moderate Buy” and a consensus price target of $164.75.
Read Our Latest Analysis on DuPont de Nemours
DuPont de Nemours Price Performance
NYSE DD opened at $151.15 on Wednesday. DuPont de Nemours has a 1 year low of $111.15 and a 1 year high of $157.98. The business’s fifty day moving average is $132.93 and its two-hundred day moving average is $138.62. The stock has a market capitalization of $20.41 billion, a P/E ratio of 67.78, a P/E/G ratio of 1.37 and a beta of 1.06. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.82 and a current ratio of 2.36.
DuPont de Nemours (NYSE:DD – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The basic materials company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.22. The business had revenue of $1.87 billion during the quarter, compared to analyst estimates of $1.84 billion. DuPont de Nemours had a return on equity of 6.85% and a net margin of 4.26%. The company’s revenue was up 4.1% compared to the same quarter last year. During the same period last year, the company posted $1.09 EPS. On average, research analysts forecast that DuPont de Nemours will post 7.49 earnings per share for the current fiscal year.
DuPont de Nemours Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be given a $0.60 dividend. The ex-dividend date is Monday, November 30th. This represents a $2.40 annualized dividend and a yield of 1.6%. DuPont de Nemours’s payout ratio is presently 533.33%.
Institutional Trading of DuPont de Nemours
Several large investors have recently made changes to their positions in the business. Parallel Advisors LLC lifted its stake in DuPont de Nemours by 1.4% in the third quarter. Parallel Advisors LLC now owns 6,340 shares of the basic materials company’s stock valued at $823,000 after buying an additional 87 shares in the last quarter. Center for Financial Planning Inc. raised its position in DuPont de Nemours by 19.7% in the 3rd quarter. Center for Financial Planning Inc. now owns 607 shares of the basic materials company’s stock valued at $79,000 after buying an additional 100 shares during the last quarter. Brandywine Oak Private Wealth LLC lifted its stake in DuPont de Nemours by 0.9% in the 3rd quarter. Brandywine Oak Private Wealth LLC now owns 12,301 shares of the basic materials company’s stock valued at $1,598,000 after acquiring an additional 111 shares in the last quarter. Americana Partners LLC lifted its stake in DuPont de Nemours by 0.4% in the 3rd quarter. Americana Partners LLC now owns 24,855 shares of the basic materials company’s stock valued at $3,228,000 after acquiring an additional 111 shares in the last quarter. Finally, Providence Wealth Advisors LLC lifted its stake in DuPont de Nemours by 2.2% in the 3rd quarter. Providence Wealth Advisors LLC now owns 5,243 shares of the basic materials company’s stock valued at $682,000 after acquiring an additional 113 shares in the last quarter. Institutional investors own 73.96% of the company’s stock.
Trending Headlines about DuPont de Nemours
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Analysts raised their targets and kept bullish ratings. UBS lifted its target to $182 and maintained a Buy rating; Citigroup raised its target to $176 with a Buy rating; and Barclays raised its target to $176 with an Overweight rating. UBS rating information Citigroup rating information Barclays rating information
- Positive Sentiment: Q3 results beat expectations and growth was broad-based. DuPont reported adjusted EPS of $2.09 versus the $1.87 consensus and revenue of about $1.9 billion, up 4% year over year; organic sales increased 5%. The company cited strong healthcare and aerospace demand. Reuters report on DuPont’s outlook
- Positive Sentiment: DuPont raised its 2026 outlook and plans further buybacks. After exceeding its third-quarter guidance, the company increased its full-year guidance and announced plans to repurchase $250 million of shares in the fourth quarter, supporting the investment case. DuPont third-quarter results
- Neutral Sentiment: A new peptide-purification product could offer a growth opportunity, but the supplied article listing does not provide enough detail to assess its likely revenue contribution. Article on DuPont’s peptide-purification product
- Negative Sentiment: DD has softened after its earnings-related surge. The coverage provided does not point to a specific adverse catalyst, so the pullback may reflect profit-taking rather than a deterioration in the reported business outlook.
About DuPont de Nemours
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
Recommended Stories
- Five stocks we like better than DuPont de Nemours
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
